Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Taxes × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 30 Breast Neoplasms 22 Carcinoma, Non-Small-Cell Lung 20 Ovarian Neoplasms 17 Fallopian Tube Neoplasms 17 Lung Neoplasms 15 Triple Negative Breast Neoplasms 13 Neoplasm Metastasis 12 Squamous Cell Carcinoma of Head and Neck 11 Endometrial Neoplasms 9 Neoplasms 7 Mouth Neoplasms 5 Cholangiocarcinoma 5 Oropharyngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma 4 Breast Neoplasms, Male 4 Anatomic Stage I Breast Cancer AJCC v8 4 Adenocarcinoma Of Esophagus 4 Stomach Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Inflammatory Breast Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma, Squamous Cell 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡